Obsessive-compulsive disorder issues pertinent to women

Women's Health

Volumn 4, Issue 4, 2008, Pages 311-313

  Nestadt, Gerald ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; EXCITATORY AMINO ACID TRANSPORTER 3; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

AGE DISTRIBUTION; ANORGASMIA; BEHAVIOR THERAPY; DIET THERAPY; DISEASE EXACERBATION; DRUG CONTRAINDICATION; DRUG DOSE REDUCTION; DRUG MEGADOSE; EDITORIAL; EXERCISE; FEMALE; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; LIBIDO DISORDER; LOW DRUG DOSE; OBSESSIVE COMPULSIVE DISORDER; ONSET AGE; PATHOPHYSIOLOGY; PREGNANCY; PREVALENCE; PULMONARY HYPERTENSION; SEX DIFFERENCE; SIDE EFFECT; TERATOLOGY; WEIGHT GAIN; WOMEN'S HEALTH;

BEHAVIOR THERAPY; FEMALE; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PSYCHIATRIC STATUS RATING SCALES; RISK ASSESSMENT; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; WOMEN'S HEALTH; WOMEN'S HEALTH SERVICES;

EID: 48749121830     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.4.4.311     Document Type: Editorial

References (27)

1. Janet P: Les Obsessions et la Prychasthenie (1st Edition). Bailliere Paris, France (1903).
2. Karno M, Golding JM: Obsessive compulsive disorder. In: Psychiatric Disorders in America. Robins LN, Regier DA (Eds). Free Press, NY, USA 204-219 (1991).
3. Weissman MM, Bland RC, Canino GJ et al.: The cross national epidemiology of obsessive-compulsive disorder. The Cross National Collaborative Group. J. Clin. Psychiatry 55(Suppl.), 5-10 (1994).
4. Nestadt G, Samuels JF, Romanoski AJ, Folstein MF, McHugh PR: Obsessions and compulsions in the community. Acta Psychiatr. Scand. 89, 219-224 (1994).
5. Nestadt G, Bienvenu OJ, Cai G, Samuels J, Eaton WW: Incidence of obsessive-compulsive disorder in adults. J. Nerv. Ment. Dis. 186, 401-406 (1998).
6. Murray CL, Lopez AD: The Global Burden of Disease. Harvard University Press, Cambridge, MA, USA (1996).
7. Steketee G: Disability and family burden in obsessive-compulsive disorder. Can. J. Psychiatry 42, 919-928 (1997).
8. Inyoue E: Similar and dissimilar manifestations of obsessive-compulsive neurosis in monozygotic twins. Am. J. Psychiatry 121, 1171-1175 (1965).
9. Carey G, Gottesman II: Twin and family studies of anxiety, phobic, and obsessive disorders. New research and changing concepts. In: Anxiety: New Research and Changing Concepts. Klein DF, Rabkin JG (Eds). Raven Press, NY, USA 117-136 (1981).
10. Nestadt G, Samuels J, Riddle M et al.: A family study of obsessive-compulsive disorder. Arch. Gen. Psychiatry 57, 358-363 (2000).
11. Pauls DL, Alsobrook JP, Goodman W, Rasmussen S, Leckman JF: A family study of obsessive-compulsive disorder. Am. J. Psychiatry. 152, 76-84 (1995).
12. Hanna GL, Himle JA, Curtis GC, Gillespie BW: A family study of obsessive-compulsive disorder with pediatric probands. Am. J. Med. Genet. B Neuropsychiatr. Genet. 134(l), 13-19 (2005).
13. Leonard HL, Swedo SE: Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS). Int. J. Neuropsychopharmacol. 4, 191-198 (2001).
14. Saxena S, Brody AL, Schwartz JM, Baxter LR: Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br. J. Psychiatry Suppl. 26-37 (1998).
15. Rauch SL, Pea W: Neurobiological models of obsessive-compulsive disorders. In: Obsessive-compulsive Disorders: Practical Management. MA Jenike, Baer I, Minichiello WE (Eds). Mosby, MA, USA 222-253 (2004).
16. Rauch SL: Neuroimaging and neurocircultry models pertaining to the neurosurgical treatment of psychiatric disorders. Neurosurg. Clin. N. Am 14 (2), 213-223 (2003).
17. Nestadt G, Lan T, Samuels J et al.: Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex, Am. J. Hum. Genet. 67(6), 1611-1616 (2000).
18. Shugart YY, Samuels J, Willour VL et al.: Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, l5q, and 6q. Mol. Psychiatry 11 (8), 763-770 (2006).
19. Wang Y, Samuels JF, Chang YC et al.: Gender differences in genetic linkage and association on 11p15 in obsessive-compulsive disorder families. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2008) (Epub ahead of print).
20. Dickel DE, Veenstra-VanderWeele J, Cox NJ et al.: Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch. Gen. Psychiatry. 63(7), 778-785 (2006).
21. Arnold PD, Sicard T, Burroughs E, Richter MA, Kennedy JL: Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch. Gen. Psychiatry. 63(7). 769-776 (2006).
22. Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB: American Psychiatric Association: Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am. J. Psychiatry. 164(7 Suppl.), 5-53 (2007).
23. Greene MI: leratogenicity of SSRIs serious concern or much ado about little? N. Engl. J. Med. 356(26), 2732-2733 (2007).
24. Alwan S. Reefhuis Rasmussen SA, Olney RS, Friedman JM: for the National Birth Defects Prevention Study: Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects N. Engl. J. Med. 356(26). 2684-2692 (2007).
25. Chambers CD, Hernandez-Diaz S, Van Marter LJ et al.: Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn N. Engl. J. Med. 354(6), 579-587 (2006).
26. Gentile S: Use of contemporary antidepressants during breastfeeding: a proposal for a specific safety index. Drug Saf. 30(2), 107-121 (2007).
27. Koran LM: Obsessive-Compulsive and Related Disorders in Adults: a Comprehensive Clinical Guide. Cambridge University Press. Cambridge, England (1999).